Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only
Public ClinicalTrials.gov record NCT02906930. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted globally. The aim of this trial is to investigate efficacy and safety of oral semaglutide versus placebo in subjects with type 2 diabetes mellitus treated with diet and exercise only.
Study identification
- NCT ID
- NCT02906930
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 703 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 20, 2016 (Actual)
- Primary completion
- Oct 30, 2017 (Actual)
- Completion
- Dec 8, 2017 (Actual)
- Last update posted
- Jul 20, 2022
2016 – 2017
United States locations
- U.S. sites
- 56
- U.S. states
- 22
- U.S. cities
- 51
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Lancaster | California | 93534 | — |
| Novo Nordisk Investigational Site | Los Angeles | California | 90057 | — |
| Novo Nordisk Investigational Site | Montclair | California | 91763 | — |
| Novo Nordisk Investigational Site | North Hollywood | California | 91606 | — |
| Novo Nordisk Investigational Site | Riverside | California | 92506 | — |
| Novo Nordisk Investigational Site | San Diego | California | 92111 | — |
| Novo Nordisk Investigational Site | San Jose | California | 95148 | — |
| Novo Nordisk Investigational Site | San Mateo | California | 94401 | — |
| Novo Nordisk Investigational Site | Doral | Florida | 33166 | — |
| Novo Nordisk Investigational Site | Hialeah | Florida | 33012 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33143 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33173 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33186 | — |
| Novo Nordisk Investigational Site | Palm Harbor | Florida | 34684-3609 | — |
| Novo Nordisk Investigational Site | Pembroke Pines | Florida | 33026 | — |
| Novo Nordisk Investigational Site | Port Charlotte | Florida | 33952 | — |
| Novo Nordisk Investigational Site | Spring Hill | Florida | 34609 | — |
| Novo Nordisk Investigational Site | Tampa | Florida | 33607 | — |
| Novo Nordisk Investigational Site | Woodstock | Georgia | 30189-4255 | — |
| Novo Nordisk Investigational Site | Honolulu | Hawaii | 96814 | — |
| Novo Nordisk Investigational Site | Blackfoot | Idaho | 83221 | — |
| Novo Nordisk Investigational Site | Nampa | Idaho | 83686-6011 | — |
| Novo Nordisk Investigational Site | Skokie | Illinois | 60077 | — |
| Novo Nordisk Investigational Site | Muncie | Indiana | 47304 | — |
| Novo Nordisk Investigational Site | Louisville | Kentucky | 40213 | — |
| Novo Nordisk Investigational Site | Metairie | Louisiana | 70002 | — |
| Novo Nordisk Investigational Site | Hyattsville | Maryland | 20782 | — |
| Novo Nordisk Investigational Site | Kalamazoo | Michigan | 49009 | — |
| Novo Nordisk Investigational Site | Rochester | Michigan | 48307 | — |
| Novo Nordisk Investigational Site | Troy | Michigan | 48098 | — |
| Novo Nordisk Investigational Site | Elkhorn | Nebraska | 68022 | — |
| Novo Nordisk Investigational Site | Brooklyn | New York | 11215 | — |
| Novo Nordisk Investigational Site | West Seneca | New York | 14224 | — |
| Novo Nordisk Investigational Site | Asheboro | North Carolina | 27203 | — |
| Novo Nordisk Investigational Site | Charlotte | North Carolina | 28277 | — |
| Novo Nordisk Investigational Site | Greensboro | North Carolina | 27408 | — |
| Novo Nordisk Investigational Site | Fargo | North Dakota | 58104 | — |
| Novo Nordisk Investigational Site | Cincinnati | Ohio | 45255 | — |
| Novo Nordisk Investigational Site | Willoughby Hills | Ohio | 44094 | — |
| Novo Nordisk Investigational Site | Norman | Oklahoma | 73069 | — |
| Novo Nordisk Investigational Site | Oklahoma City | Oklahoma | 73112 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19140 | — |
| Novo Nordisk Investigational Site | Spartanburg | South Carolina | 29303 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75230 | — |
| Novo Nordisk Investigational Site | Houston | Texas | 77058 | — |
| Novo Nordisk Investigational Site | Mesquite | Texas | 75149 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78215 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78224 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78228-3419 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78230 | — |
| Novo Nordisk Investigational Site | Sugar Land | Texas | 77479 | — |
| Novo Nordisk Investigational Site | Waco | Texas | 76710 | — |
| Novo Nordisk Investigational Site | Bountiful | Utah | 84010 | — |
| Novo Nordisk Investigational Site | Norfolk | Virginia | 23510-2015 | — |
| Novo Nordisk Investigational Site | Richmond | Virginia | 23219 | — |
| Novo Nordisk Investigational Site | Salem | Virginia | 24153-6404 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02906930, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 20, 2022 · Synced Oct 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02906930 live on ClinicalTrials.gov.